American Oncology Network (AON) announced that they have entered into a definitive business combination agreement and will become a public company.
Fort Myers, Fla. & Los Angeles, October 6, 2022 – American Oncology Network, LLC (AON) announced that they have entered into a definitive business combination agreement with Digital Transformation Opportunities Corp. (DTOC) pursuant to which AON will become a public company (the “Business Combination”).
Upon the closing of the Business Combination, AON’s senior leadership team will continue to serve in their current roles. The combined company will be led by AON’s chief executive officer (CEO) Todd Schonherz, President and chief development officer Brad Prechtl, chief financial officer David Gould, and chief medical officer Dr Stephen "Fred" Divers. AON’s existing board, which is composed of practicing medical oncologists, is expected to remain in place and will be joined by additional members affiliated with DTOC.
“This transaction represents the next step in AON’s journey to become the leading platform for community-based oncology practices. Since launching the AON platform in 2018, we’ve been able to drive consistently strong growth by providing our physician partners with a strong suite of practice management tools and ancillary services as well as access to the financial benefits associated with being integrated with a scaled platform," said AON CEO Todd Schonherz.
"We look forward to continuing to grow our network of physician partners and supporting them with our physician practice management platform.”
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More